New studies reveal rare but real risk of GLP-1 drugs

New studies indicate that GLP-1 drugs used for obesity or diabetes are linked to a rare but real risk of hair loss, which is higher compared to other diabetes medications. The risk is described as low but elevated relative to alternative treatments.